OV-825

N/A

Report date: 2024/04/23 11:59:21
NME

Base Information

Drug NameOV-825
Drug Alias NameOV-825
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionHeterogeneous nuclear ribonucleoproteins A2/B1 modulatorsRNA interference
TargetsHeterogeneous nuclear ribonucleoproteins A2/B1
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOvid Therapeutics IncColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesOvid Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A